Medtronic Plc agreed to buy the shares it doesn’t already own in Mazor Robotics Ltd. in a deal valuing the company at $1.6 billion, as the medical equipment giant expands its leadership in the market for spinal surgery.
To read the entire story, you must be logged in.
Please log in now or register with us.
